JUPITER NEUROSCIENCES, INC. (JUNS)

↓ Download CSV

CIK 0001679628 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, JUPITER NEUROSCIENCES, INC. reported revenue of $21.8K. The company ran a net loss, with a net margin of -39662.8% and a gross margin of 80.6%. It held $5.56M in total assets against $7.40M in total liabilities.

Key ratios (FY2025)

80.6%
Gross margin
-40873.2%
Operating margin
-39662.8%
Net margin
Metric (FY)2025202420232022
Revenue$21.8K$0
Cost of Revenue$4.2K
Gross Profit$17.6K
Operating Income-$8.91M-$3.09M-$3.87M
Net Income-$8.64M-$2.44M-$4.78M
EPS (Diluted)$-0.25$-0.08$-0.18
Total Assets$5.56M$6.20M$148.6K
Total Liabilities$7.40M$2.03M$5.95M
Shareholders' Equity-$1.83M$4.17M-$5.80M-$7.14M
Operating Cash Flow-$5.41M-$3.91M-$481.0K
Shares Outstanding34.45M33.10M26.53M